Oral GED0301 Phase 1b Results Show Clinical Remission and Endoscopic Response at Week 12 in Patients with Active Crohns Disease

Clinical improvement observed early with highest clinical response and remission rates in the 12week treatment group Endoscopic improvement seen across all treatment groups at 12 weeks Safety and tolerability were consistent with previous studies VIENNA&am...